Advertisement
Canada markets open in 4 hours 51 minutes
  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CAD/USD

    0.7301
    -0.0000 (-0.01%)
     
  • CRUDE OIL

    82.86
    +0.96 (+1.17%)
     
  • Bitcoin CAD

    90,531.36
    -142.58 (-0.16%)
     
  • CMC Crypto 200

    1,393.80
    -20.96 (-1.48%)
     
  • GOLD FUTURES

    2,320.50
    -25.90 (-1.10%)
     
  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     
  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     
  • NASDAQ futures

    17,388.25
    +38.25 (+0.22%)
     
  • VOLATILITY

    16.56
    -0.38 (-2.24%)
     
  • FTSE

    8,060.61
    +36.74 (+0.46%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6832
    -0.0018 (-0.26%)
     

BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript

BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript

Participating with me today are CEO, Jon Stonehouse; CFO, Anthony Doyle; chief commercial officer, Charlie Gayer; and chief R&D officer, Dr. 2022 was another outstanding year for ORLADEYO as we doubled sales in our second full year of launch on top of the fantastic start we had in the first year.